ThomasVincentJonesMDMPH
Internal Medicine • Hershey, PAGeriatric Medicine
Safety Risk Lead, Senior Director Safety Surveillance and Risk Management
Dr. Jones is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
255 William Dr
Hershey, PA 17033Phone+1 717-533-0681
Education & Training
UNC MPH, Epidemiology, 1990
University of North Carolina HospitalsFellowship, Robert Wood Johnson Clinical Scholars Program, 1986 - 1988
University of Rochester School of Medicine and DentistryClass of 1983
Certifications & Licensure
PA State Medical License 1998 - 2024
NC State Medical License 1986 - 1992- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 138 citationsIncidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and f...Philip J. Mease, Christina Charles-Schoeman, Stanley Cohen, Lara Fallon, John Woolcott
Annals of the Rheumatic Diseases. 2020-08-05 - 32 citationsAdverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofac...Gerd R Burmester, Peter Nash, Bruce E. Sands, Kim A. Papp, Lori Stockert
RMD Open. 2021-05-01 - 33 citationsChanges in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III...Dafna D. Gladman, Christina Charles-Schoeman, Iain B. McInnes, Douglas J. Veale, Bruce H. Thiers
Arthritis Care & Research. 2019-10-01
Journal Articles
- An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational...Burmester GR, Drug Safety
- An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational...Burmester GR, Drug Safety
- An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational...Burmester GR, Drug Safety
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
